4//SEC Filing
Seyedkazemi Setareh 4
Accession 0001415889-25-013444
CIK 0001501756other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:45 PM ET
Size
5.3 KB
Accession
0001415889-25-013444
Insider Transaction Report
Form 4
Seyedkazemi Setareh
CHIEF DEVELOPMENT OFFICER
Transactions
- Sale
Common Stock
2025-05-15$2.00/sh−924$1,848→ 13,768 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected to satisfy certain tax obligations of the Reporting Person incurred with the vesting and settlement of certain performance stock units.
- [F2]Price reported is a weighted-average sale price. The shares were sold at prices ranging from $1.98 to $2.01. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
Adverum Biotechnologies, Inc.
CIK 0001501756
Entity typeother
Related Parties
1- filerCIK 0001903088
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 4:45 PM ET
- Size
- 5.3 KB